As mentioned I believe voit and clarys explanation - too hard for a tiny aussie speccy to afford. Could it have saved us, maybe! Should it have been included in hindsight, yes! Are the BOD responsible... they know science better than us x 100, so likely, yes! But I dont know enough about science to point the finger so convincingly. As mentioned Im still unsure as to the professionalism of the ph2a and the mri attached to that. But lets assume the ph2a mri was correct (even tho the pul proved to be unaligned w 2b). If the mri together with cd49d stuff showed drug efficacy, and was accepted by fda, my non scientific guess would say 'the drug worked'. But, how well is the question, as CAP and DUVY had their statistically meaningful puls to compete with... with a primary endpoint of pul inline w placebo we'd prob be in very rough waters, but perhaps not on this coral reef.
Hindsight is a glorious thing.
- Forums
- ASX - By Stock
- PER
- Ann: Webinar Presentation - Phase IIb study of avicursen
PER
percheron therapeutics limited
Add to My Watchlist
0.00%
!
1.0¢

Ann: Webinar Presentation - Phase IIb study of avicursen, page-29
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.87M |
Open | High | Low | Value | Volume |
1.0¢ | 1.0¢ | 1.0¢ | $5.737K | 573.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3633138 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 3174000 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3633138 | 0.010 |
6 | 5659202 | 0.009 |
4 | 1260267 | 0.008 |
5 | 2282854 | 0.007 |
2 | 3200000 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 3174000 | 4 |
0.012 | 1439598 | 4 |
0.013 | 1033000 | 2 |
0.014 | 2367834 | 5 |
0.015 | 1500000 | 1 |
Last trade - 15.22pm 17/06/2025 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
SPONSORED BY The Market Online